DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: acyclovir

Summary for Generic Name: acyclovir

Tradenames:6
Patents:5
Applicants:32
NDAs:58
Drug Master File Entries: see list52
Suppliers: see list8
Therapeutic Class:Antivirals

Clinical Trials for: acyclovir

Effect of Body Mass on Acyclovir Pharmacokinetics
Status: Recruiting Condition: Hematological Malignancy; Pharmacokinetics of Acyclovir

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Status: Completed Condition: Genital Herpes; HIV Infection

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
Status: Completed Condition: HIV Infections; Herpes Genitalis

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
Status: Active, not recruiting Condition: Genital Herpes

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
Status: Completed Condition: Herpes Simplex; HIV Infections

HSV-2 Shedding Resolution After Acyclovir Treatment
Status: Completed Condition: Genital Herpes

Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
Status: Completed Condition: Herpes Simplex

Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Status: Completed Condition: Herpes Simplex

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
Status: Completed Condition: HIV Infections; Herpesvirus 2, Human

Efficacy of Antiviral Medications in Controlling Vertigo Attacks of Patients With Meniere's Disease
Status: Recruiting Condition: Meniere's Disease

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Valeant Bermuda
XERESE
acyclovir; hydrocortisone
CREAM;TOPICAL022436Jul 31, 2009RXYes<disabled>NEW PATIENT POPULATION
Valeant Bermuda
XERESE
acyclovir; hydrocortisone
CREAM;TOPICAL022436Jul 31, 2009RXYes7,223,387<disabled>Y
Valeant Bermuda
XERESE
acyclovir; hydrocortisone
CREAM;TOPICAL022436Jul 31, 2009RXYes7,223,387<disabled>YNEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
Valeant Bermuda
XERESE
acyclovir; hydrocortisone
CREAM;TOPICAL022436Jul 31, 2009RXYes6,514,980<disabled>Y
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc